These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23563021)

  • 21. Negative effects of chronic oral chlorpromazine and olanzapine treatment on the performance of tasks designed to assess spatial learning and working memory in rats.
    Terry AV; Warner SE; Vandenhuerk L; Pillai A; Mahadik SP; Zhang G; Bartlett MG
    Neuroscience; 2008 Oct; 156(4):1005-16. PubMed ID: 18801413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Acetylcysteine and Aripiprazole Improve Social Behavior and Cognition and Modulate Brain BDNF Levels in a Rat Model of Schizophrenia.
    Rogóż Z; Kamińska K; Lech MA; Lorenc-Koci E
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of spatial recognition memory and object discrimination after chronic administration of haloperidol, amitriptyline, sodium valproate or olanzapine in normal and anhedonic rats.
    Orsetti M; Colella L; Dellarole A; Canonico PL; Ghi P
    Int J Neuropsychopharmacol; 2007 Jun; 10(3):345-57. PubMed ID: 16734936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of haloperidol, olanzapine, ziprasidone, and PHA-543613 on spatial learning and memory in the Morris water maze test in naïve and MK-801-treated mice.
    Ning H; Cao D; Wang H; Kang B; Xie S; Meng Y
    Brain Behav; 2017 Aug; 7(8):e00764. PubMed ID: 28828223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olanzapine-induced triglyceride and aminotransferase elevations without weight gain or hyperglycemia normalized after switching to aripiprazole.
    Pawelczyk T; Pawelczyk A; Rabe-Jablonska J
    J Psychiatr Pract; 2014 Jul; 20(4):301-7. PubMed ID: 25036587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
    J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice.
    Fejgin K; Safonov S; Pålsson E; Wass C; Engel JA; Svensson L; Klamer D
    Psychopharmacology (Berl); 2007 Apr; 191(2):377-85. PubMed ID: 17235612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress.
    Park SW; Phuong VT; Lee CH; Lee JG; Seo MK; Cho HY; Fang ZH; Lee BJ; Kim YH
    Neurosci Res; 2011 Dec; 71(4):335-40. PubMed ID: 21893111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia.
    Suzuki H; Gen K; Inoue Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):161-8. PubMed ID: 21047544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.
    Chrzanowski WK; Marcus RN; Torbeyns A; Nyilas M; McQuade RD
    Psychopharmacology (Berl); 2006 Dec; 189(2):259-66. PubMed ID: 17058105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine.
    Kern RS; Green MF; Cornblatt BA; Owen JR; McQuade RD; Carson WH; Ali M; Marcus R
    Psychopharmacology (Berl); 2006 Aug; 187(3):312-20. PubMed ID: 16810506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats.
    Ortega-Alvaro A; Gibert-Rahola J; Micó JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):104-11. PubMed ID: 16226364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats.
    Kalinichev M; Rourke C; Daniels AJ; Grizzle MK; Britt CS; Ignar DM; Jones DN
    Psychopharmacology (Berl); 2005 Oct; 182(2):220-31. PubMed ID: 16001110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of gabapentin on cognitive processes in rats not exposed and exposed to tobacco smoke during fetal life.
    Czubak A; Nowakowska E; Kus K; Sadowski C; Matschay A
    Hum Exp Toxicol; 2008 Dec; 27(12):883-94. PubMed ID: 19273543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.
    Schlagenhauf F; Dinges M; Beck A; Wüstenberg T; Friedel E; Dembler T; Sarkar R; Wrase J; Gallinat J; Juckel G; Heinz A
    Schizophr Res; 2010 May; 118(1-3):189-200. PubMed ID: 20189356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripirazole-olanzapine combination for treatment of schizophrenia.
    Duggal HS
    Can J Psychiatry; 2004 Feb; 49(2):151. PubMed ID: 15065751
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of antidepressant like property of amisulpride per se and its comparison with fluoxetine and olanzapine using forced swimming test in albino mice.
    Pawar GR; Agrawal RP; Phadnis P; Paliwal A; Vyas S; Solanki P
    Acta Pol Pharm; 2009; 66(3):327-31. PubMed ID: 19645334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial of olanzapine improving memory deficits in Han Chinese patients with first-episode schizophrenia.
    Wang CH; Li Y; Yang J; Su LY; Geng YG; Li H; Wang JK; Mu JL
    Schizophr Res; 2013 Mar; 144(1-3):129-35. PubMed ID: 23352776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile.
    Hirose T; Uwahodo Y; Yamada S; Miwa T; Kikuchi T; Kitagawa H; Burris KD; Altar CA; Nabeshima T
    J Psychopharmacol; 2004 Sep; 18(3):375-83. PubMed ID: 15358981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.
    Newcomer JW; Campos JA; Marcus RN; Breder C; Berman RM; Kerselaers W; L'italien GJ; Nys M; Carson WH; McQuade RD
    J Clin Psychiatry; 2008 Jul; 69(7):1046-56. PubMed ID: 18605811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.